• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

超声和乳腺钼靶检查对导管癌的检测:与大小相关的不准确性。

Detection of Ductal Carcinoma by Ultrasound and Mammography: Size-dependent Inaccuracy.

作者信息

Eichler Christian, Abrar Sharareh, Puppe Julian, Arndt Mariam, Ohlinger Ralf, Hahn Markus, Warm Mathias

机构信息

Breast Center, Municipal Hospital Holweide, Cologne, Germany

Department of Gynecology and Obstetrics, Municipal Hospital Holweide, Cologne, Germany.

出版信息

Anticancer Res. 2017 Sep;37(9):5065-5070. doi: 10.21873/anticanres.11923.

DOI:10.21873/anticanres.11923
PMID:28870935
Abstract

BACKGROUND

Retrospective analysis of breast cancer imaging methods is a common tool for evaluating the effectiveness of ultrasound and mammography regarding ductal carcinoma in situ (DCIS). No large number subpopulation of pure DCIS has been reported. It is however known that mammography and ultrasound underestimate tumor dimension with increasing tumor size. We aimed to quantify this discrepancy.

MATERIALS AND METHODS

This retrospective analysis reviewed the ultrasound and mammography data from 173 patients with DCIS at the University of Cologne - Department of Gynecology and Obstetrics between the years 2007 and 2010. Of these 173 patients, 34 fulfilled the DCIS analysis requirements and were evaluated in this study.

RESULTS

Overall, ultrasound underestimated tumor size 79.4% of the time, while overestimating only 20.6% of the time. Mammography underestimated tumor size in 50%, overestimated in 38.2%, correctly estimating in 11.8%. Over and underestimation distributions differed drastically above and a cut-off point of ≤2 cm actual tumor size, with a significant shift toward severe underestimation by both methods above a tumor size of 2 cm. DCIS misestimation was defined as the absolute value of the difference between actual tumor size and pre-surgical measurement by an imaging method. Mean DCIS size misestimation (actual tumor size ≤2 cm) was 3 mm for ultrasound and 6.2 mm for mammography.

CONCLUSION

We support previous findings that ultrasound and mammography lose accuracy with increasing tumor size. Nonetheless, ultrasound may be more useful in estimation of DCIS size for tumors ≤2 cm than previously expected.

摘要

背景

对乳腺癌成像方法进行回顾性分析是评估超声和乳腺X线摄影对导管原位癌(DCIS)有效性的常用手段。尚未有大量关于纯DCIS亚群的报道。然而,已知乳腺X线摄影和超声会随着肿瘤尺寸增大而低估肿瘤大小。我们旨在量化这种差异。

材料与方法

这项回顾性分析回顾了2007年至2010年间科隆大学妇产科173例DCIS患者的超声和乳腺X线摄影数据。在这173例患者中,34例符合DCIS分析要求并在本研究中进行评估。

结果

总体而言,超声在79.4%的情况下低估肿瘤大小,而高估仅占20.6%的时间。乳腺X线摄影低估肿瘤大小的占50%,高估的占38.2%,正确估计的占11.8%。在实际肿瘤大小≤2 cm的临界点以上,高估和低估分布差异极大,两种方法在肿瘤大小超过2 cm时均显著转向严重低估。DCIS错误估计定义为实际肿瘤大小与术前成像方法测量值之间差异的绝对值。对于实际肿瘤大小≤2 cm的情况,超声的平均DCIS大小错误估计为3 mm,乳腺X线摄影为6.2 mm。

结论

我们支持先前的研究结果,即超声和乳腺X线摄影会随着肿瘤大小增加而失去准确性。尽管如此,对于≤2 cm的肿瘤,超声在估计DCIS大小方面可能比先前预期的更有用。

相似文献

1
Detection of Ductal Carcinoma by Ultrasound and Mammography: Size-dependent Inaccuracy.超声和乳腺钼靶检查对导管癌的检测:与大小相关的不准确性。
Anticancer Res. 2017 Sep;37(9):5065-5070. doi: 10.21873/anticanres.11923.
2
Measurements using mammography and ultrasonography underestimate the size of high-volume ductal carcinoma in situ.使用乳腺 X 线摄影术和超声检查会低估大体积导管原位癌的大小。
Am J Surg. 2021 Jun;221(6):1167-1171. doi: 10.1016/j.amjsurg.2021.03.043. Epub 2021 Mar 24.
3
Preoperative prediction of the size of pure ductal carcinoma in situ using three imaging modalities as compared to histopathological size: does magnetic resonance imaging add value?术前应用三种影像学方法预测单纯导管原位癌的大小与组织病理学大小的比较:磁共振成像是否有价值?
Breast Cancer Res Treat. 2017 Jul;164(2):437-444. doi: 10.1007/s10549-017-4252-2. Epub 2017 Apr 24.
4
Comparison of mammography, ultrasound, and MRI in size assessment of ductal carcinoma in situ with histopathologic correlation.乳腺钼靶、超声及磁共振成像在导管原位癌大小评估中的比较及其与组织病理学的相关性
Acta Radiol. 2017 Dec;58(12):1434-1441. doi: 10.1177/0284185117698860. Epub 2017 Mar 10.
5
Accuracy of Breast Magnetic Resonance Imaging Compared to Mammography in the Preoperative Detection and Measurement of Pure Ductal Carcinoma In Situ: A Retrospective Analysis.乳腺磁共振成像与乳腺 X 线摄影在术前检测和测量单纯导管原位癌中的准确性比较:一项回顾性分析。
Acad Radiol. 2019 Jun;26(6):760-765. doi: 10.1016/j.acra.2018.07.013. Epub 2018 Aug 24.
6
Comparison of Clinical and Pathologic Characteristics of Ductal Carcinoma in Situ Detected on Mammography versus Ultrasound Only in Asymptomatic Patients.仅在无症状患者中,比较乳腺钼靶与超声检查发现的导管原位癌的临床和病理特征
Ultrasound Med Biol. 2019 Jan;45(1):68-77. doi: 10.1016/j.ultrasmedbio.2018.09.003. Epub 2018 Oct 12.
7
Mammographic extent of microcalcifications and oestrogen receptor expression affect preoperative breast carcinoma in situ size estimation.乳腺钼靶检查中微钙化的范围和雌激素受体表达影响术前原位乳腺癌大小的估计。
Breast Cancer. 2017 May;24(3):466-472. doi: 10.1007/s12282-016-0729-9. Epub 2016 Sep 17.
8
Comparison of Mammography and Ultrasonography for Tumor Size of DCIS of Breast Cancer.乳腺导管原位癌肿瘤大小的乳腺钼靶摄影与超声检查比较
Curr Med Imaging Rev. 2019;15(2):209-213. doi: 10.2174/1573405614666180131163321.
9
Histopathological characteristics of breast ductal carcinoma in situ and association with imaging findings.乳腺导管原位癌的组织病理学特征及其与影像学表现的相关性。
Breast Cancer. 2016 May;23(3):491-8. doi: 10.1007/s12282-015-0592-0. Epub 2015 Feb 3.
10
The use of radioactive iodine-125 seed localization in patients with non-palpable breast cancer: a comparison with the radioguided occult lesion localization with 99m technetium.放射性碘-125种子定位在不可触及乳腺癌患者中的应用:与锝-99m放射性引导隐匿病变定位的比较
Eur J Surg Oncol. 2015 Apr;41(4):553-8. doi: 10.1016/j.ejso.2015.01.022. Epub 2015 Feb 3.

引用本文的文献

1
Digital morphometry illustrates a relationship between percentage of ductal carcinoma in-situ in breast needle core biopsy and margin status at lumpectomy.数字形态计量学表明了乳腺针芯活检中导管原位癌的百分比与肿块切除时切缘状态之间的关系。
J Pathol Inform. 2025 Apr 30;18:100445. doi: 10.1016/j.jpi.2025.100445. eCollection 2025 Aug.
2
Case Report: Exploration of changes in serum immunoinflammation-related protein complexes of patients with metastatic breast cancer.病例报告:转移性乳腺癌患者血清免疫炎症相关蛋白复合物变化的探索
Front Oncol. 2023 Jul 21;13:1207991. doi: 10.3389/fonc.2023.1207991. eCollection 2023.
3
Treatment Response Monitoring Using a Tumor-Informed Circulating Tumor DNA Test in an Advanced Triple-Negative Breast Cancer Patient: A Case Report.
在一名晚期三阴性乳腺癌患者中使用肿瘤信息循环肿瘤DNA检测进行治疗反应监测:病例报告
Case Rep Oncol. 2022 May 2;15(2):473-479. doi: 10.1159/000524324. eCollection 2022 May-Aug.
4
Radiological Underestimation of Tumor Size as a Relevant Risk Factor for Positive Margin Rate in Breast-Conserving Therapy of Pure Ductal Carcinoma In Situ (DCIS).在纯导管原位癌(DCIS)保乳治疗中,肿瘤大小的放射学低估作为切缘阳性率的相关危险因素。
Cancers (Basel). 2022 May 11;14(10):2367. doi: 10.3390/cancers14102367.
5
The Emerging Role of Circulating Tumor DNA in the Management of Breast Cancer.循环肿瘤DNA在乳腺癌管理中的新兴作用
Cancers (Basel). 2021 Jul 29;13(15):3813. doi: 10.3390/cancers13153813.
6
The Impact of Preoperative Breast MRI on Surgical Margin Status in Breast Cancer Patients Recalled at Biennial Screening Mammography: An Observational Cohort Study.术前乳腺 MRI 对在每两年一次的筛查性乳房 X 光检查中召回的乳腺癌患者手术切缘状态的影响:一项观察性队列研究。
Ann Surg Oncol. 2021 Oct;28(11):5929-5938. doi: 10.1245/s10434-021-09868-1. Epub 2021 Apr 1.